Beat the rise! Delivery fees are going up soon. INFO

Close Notification

Your cart does not contain any items

Human Pharmaceuticals in the Environment

Current and Future Perspectives

Bryan W. Brooks Duane B. Huggett

$251.95   $201.58

Hardback

Not in-store but you can order this
How long will it take?

QTY:

English
Springer-Verlag New York Inc.
12 June 2012
Human interaction with the environment remains one of the most pervasive facets of modern society. In a world characterized by rapid population growth, unprecedented global trade and digital communications, energy security, natural resource scarcities, climatic changes and environmental quality, emerging diseases and public health, biodiversity and habitat modifications are routinely touted by the popular press as they canvas global political agendas and scholarly endeavors.
Edited by:   ,
Imprint:   Springer-Verlag New York Inc.
Country of Publication:   United States
Edition:   2012 ed.
Volume:   4
Dimensions:   Height: 235mm,  Width: 155mm,  Spine: 23mm
Weight:   635g
ISBN:   9781461434191
ISBN 10:   146143419X
Series:   Emerging Topics in Ecotoxicology
Pages:   304
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Hardback
Publisher's Status:   Active
Perspectives on Human Pharmaceuticals in the Environment.- Environmental Risk Assessment for Human Pharmaceuticals – the Current State of International Regulations.- Regulation of Pharmaceuticals in the Environment: The United States.- Environmental Fate of Human Pharmaceuticals.- Environmental Comparative Pharmacology: Theory and Application.- A Look Backwards at Environmental Risk Assessment: An Approach to Reconstructing Ecological Exposures.- Considerations and Criteria for the Incorporation of Mechanistic Sub-Lethal Endpoints into Environmental Risk Assessment for Biologically Active Compounds.- Human Health Risk Assessment for Pharmaceuticals in the Environment: Existing Practice, Uncertainty, and Future Directions.- Wastewater and Drinking Water Treatment Technologies.- Pharmaceutical Take Back Programs.- Index.

See Also